Supplementary Figure 2. The T84-M85 loop of MD-2 at the dimerisation interface undergoes a conformational change induced by LPS binding.
The LPS-induced conformational change of the T84-M85 loop, as well as the F126 loop, becomes apparent when the MD-2 molecules of the Eritoran antagonist complex (PDB accession code 2Z65, Eritoran shown in yellow) and the LPS agonist complex (PDB accession code 3FXI, LPS shown in gray) of both crystal structures are superimposed. The primary MD-2 binding site is conserved in both complexes, whereas dimerization is impaired in the Eritoran complex due to steric clashes between the TLR4 molecule at the dimer interface and the flexible loops of MD-2.
